{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:32:27Z","timestamp":1791199947338,"version":"4.2.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T00:00:00Z","timestamp":1473984000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00535-016-1264-3","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T09:17:48Z","timestamp":1474017468000},"page":"164-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Nonalcoholic fatty liver disease in Asia: emerging perspectives"],"prefix":"10.1007","volume":"52","author":[{"given":"Wai-Kay","family":"Seto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Fung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,16]]},"reference":[{"issue":"5","key":"1264_CR1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrgastro.2013.34","volume":"10","author":"GC Farrell","year":"2013","unstructured":"Farrell GC, Wong VW, Chitturi S. NAFLD in Asia\u2014as common and important as in the West. Nat Rev Gastroenterol Hepatol. 2013;10(5):307\u201318.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"1264_CR2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","volume":"40","author":"JD Browning","year":"2004","unstructured":"Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387\u201395.","journal-title":"Hepatology"},{"issue":"1","key":"1264_CR3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140(1):124\u201331.","journal-title":"Gastroenterology"},{"issue":"1","key":"1264_CR4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MEG.0b013e32832fcdf0","volume":"22","author":"L Caballeria","year":"2010","unstructured":"Caballeria L, Pera G, Auladell MA, et al. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Eur J Gastroenterol Hepatol. 2010;22(1):24\u201332.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"1264_CR5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00535-015-1050-7","volume":"50","author":"S Watanabe","year":"2015","unstructured":"Watanabe S, Hashimoto E, Ikejima K, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. J Gastroenterol. 2015;50(4):364\u201377.","journal-title":"J Gastroenterol"},{"issue":"5","key":"1264_CR6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00535-012-0533-z","volume":"47","author":"Y Eguchi","year":"2012","unstructured":"Eguchi Y, Hyogo H, Ono M, et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol. 2012;47(5):586\u201395.","journal-title":"J Gastroenterol"},{"issue":"3","key":"1264_CR7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3350\/cmh.2013.19.3.266","volume":"19","author":"EH Jeong","year":"2013","unstructured":"Jeong EH, Jun DW, Cho YK, et al. Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea. Clin Mol Hepatol. 2013;19(3):266\u201372.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"1264_CR8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/liv.12619","volume":"35","author":"J Fung","year":"2015","unstructured":"Fung J, Lee CK, Chan M, et al. High prevalence of non-alcoholic fatty liver disease in the Chinese\u2014results from the Hong Kong liver health census. Liver Int. 2015;35(2):542\u20139.","journal-title":"Liver Int"},{"issue":"1","key":"1264_CR9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/jgh.12428","volume":"29","author":"Z Li","year":"2014","unstructured":"Li Z, Xue J, Chen P, et al. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. J Gastroenterol Hepatol. 2014;29(1):42\u201351.","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"1264_CR10","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/jgh.12290","volume":"28","author":"J Yan","year":"2013","unstructured":"Yan J, Xie W, Ou WN, et al. Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, China. J Gastroenterol Hepatol. 2013;28(10):1654\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"1264_CR11","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1017\/S0007114516000386","volume":"115","author":"HL Zhai","year":"2016","unstructured":"Zhai HL, Wang NJ, Han B, et al. Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)). Br J Nutr. 2016;115:1352\u20139.","journal-title":"Br J Nutr."},{"issue":"8","key":"1264_CR12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00004836-200609000-00016","volume":"40","author":"CH Chen","year":"2006","unstructured":"Chen CH, Huang MH, Yang JC, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 2006;40(8):745\u201352.","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"1264_CR13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eurger.2012.11.004","volume":"4","author":"SC Hung","year":"2013","unstructured":"Hung SC, Lai SW, Chen MC, et al. Prevalence and related factors of non-alcoholic fatty liver disease among the elderly in Taiwan. Eur Geriatr Med. 2013;4(2):78\u201381.","journal-title":"Eur Geriatr Med"},{"issue":"2","key":"1264_CR14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s12072-012-9359-2","volume":"7","author":"SC Goh","year":"2013","unstructured":"Goh SC, Ho EL, Goh KL. Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia. Hepatol Int. 2013;7(2):548\u201354.","journal-title":"Hepatol Int"},{"key":"1264_CR15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/gastro\/gov047","volume":"4","author":"GB Goh","year":"2016","unstructured":"Goh GB, Kwan C, Lim SY, et al. Perceptions of non-alcoholic fatty liver disease \u2013 an Asian community-based study. Gastroenterol Rep (Oxf). 2016;4:131\u20135.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"3","key":"1264_CR16","first-page":"145","volume":"14","author":"SB Cahyono","year":"2013","unstructured":"Cahyono SB, Bayupurnama P, Ratnasari N, et al. Ultrasound-diagnosed non-alcoholic fatty liver disease among medical check up patients. Indones J Gastroenterol Hepatol Dis Endosc. 2013;14(3):145\u20139.","journal-title":"Indones J Gastroenterol Hepatol Dis Endosc"},{"issue":"7","key":"1264_CR17","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1440-1746.2009.05831.x","volume":"24","author":"AS Dassanayake","year":"2009","unstructured":"Dassanayake AS, Kasturiratne A, Rajindrajith S, et al. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J Gastroenterol Hepatol. 2009;24(7):1284\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"1264_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1665-2681(19)31922-2","volume":"6","author":"D Amarapurkar","year":"2007","unstructured":"Amarapurkar D, Kamani P, Patel N, et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol. 2007;6(3):161\u20133.","journal-title":"Ann Hepatol"},{"issue":"3","key":"1264_CR19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gutjnl-2011-300342","volume":"61","author":"VW Wong","year":"2012","unstructured":"Wong VW, Chu WC, Wong GL, et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut. 2012;61(3):409\u201315.","journal-title":"Gut"},{"issue":"2","key":"1264_CR20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.20554","volume":"41","author":"SR Weston","year":"2005","unstructured":"Weston SR, Leyden W, Murphy R, et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology. 2005;41(2):372\u20139.","journal-title":"Hepatology"},{"issue":"10","key":"1264_CR21","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00535-003-1178-8","volume":"38","author":"S Kojima","year":"2003","unstructured":"Kojima S, Watanabe N, Numata M, et al. Increase in the prevalence of fatty liver in Japan over the past 12\u00a0years: analysis of clinical background. J Gastroenterol. 2003;38(10):954\u201361.","journal-title":"J Gastroenterol"},{"issue":"18","key":"1264_CR22","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.3748\/wjg.v21.i18.5695","volume":"21","author":"JZ Zhu","year":"2015","unstructured":"Zhu JZ, Zhou QY, Wang YM, et al. Prevalence of fatty liver disease and the economy in China: a systematic review. World J Gastroenterol. 2015;21(18):5695\u2013706.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1264_CR23","first-page":"383","volume":"25","author":"L Shi","year":"2012","unstructured":"Shi L, Liu ZW, Li Y, et al. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle\/dietary habits among university faculty and staff in Chengdu. Biomed Environ Sci. 2012;25(4):383\u201391.","journal-title":"Biomed Environ Sci"},{"issue":"28","key":"1264_CR24","first-page":"9338","volume":"20","author":"W Nseir","year":"2014","unstructured":"Nseir W, Hellou E, Assy N. Role of diet and lifestyle changes in nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(28):9338\u201344.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1264_CR25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2014.08.041","volume":"62","author":"VW Wong","year":"2015","unstructured":"Wong VW, Wong GL, Yeung DK, et al. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. J Hepatol. 2015;62(1):182\u20139.","journal-title":"J Hepatol"},{"issue":"5","key":"1264_CR26","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.21827","volume":"46","author":"G Bedogni","year":"2007","unstructured":"Bedogni G, Miglioli L, Masutti F, et al. Incidence and natural course of fatty liver in the general population: the Dionysos study. Hepatology. 2007;46(5):1387\u201391.","journal-title":"Hepatology"},{"issue":"5","key":"1264_CR27","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jhep.2011.12.011","volume":"56","author":"S Zelber-Sagi","year":"2012","unstructured":"Zelber-Sagi S, Lotan R, Shlomai A, et al. Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol. 2012;56(5):1145\u201351.","journal-title":"J Hepatol"},{"issue":"2","key":"1264_CR28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/07435800.2014.952014","volume":"40","author":"Y Tao","year":"2015","unstructured":"Tao Y, Gu H, Wu J, et al. Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects. Endocr Res. 2015;40(2):74\u20138.","journal-title":"Endocr Res"},{"issue":"8","key":"1264_CR29","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.sleep.2015.02.542","volume":"16","author":"TC Chou","year":"2015","unstructured":"Chou TC, Liang WM, Wang CB, et al. Obstructive sleep apnea is associated with liver disease: a population-based cohort study. Sleep Med. 2015;16(8):955\u201360.","journal-title":"Sleep Med"},{"issue":"12","key":"1264_CR30","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40(12):1461\u20135.","journal-title":"Nat Genet"},{"key":"1264_CR31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2350-13-113","volume":"13","author":"Y Li","year":"2012","unstructured":"Li Y, Xing C, Tian Z, et al. Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population. BMC Med Genet. 2012;13:113.","journal-title":"BMC Med Genet"},{"issue":"6","key":"1264_CR32","doi-asserted-by":"crossref","first-page":"e38322","DOI":"10.1371\/journal.pone.0038322","volume":"7","author":"T Kawaguchi","year":"2012","unstructured":"Kawaguchi T, Sumida Y, Umemura A, et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS One. 2012;7(6):e38322.","journal-title":"PLoS One"},{"issue":"5","key":"1264_CR33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/met.2012.0064","volume":"11","author":"SP Bhatt","year":"2013","unstructured":"Bhatt SP, Nigam P, Misra A, et al. Genetic variation in the patatin-like phospholipase domain-containing protein-3 (PNPLA-3) gene in Asian Indians with nonalcoholic fatty liver disease. Metab Syndr Relat Disord. 2013;11(5):329\u201335.","journal-title":"Metab Syndr Relat Disord"},{"issue":"7","key":"1264_CR34","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00439-012-1141-y","volume":"131","author":"SM Zain","year":"2012","unstructured":"Zain SM, Mohamed R, Mahadeva S, et al. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease. Hum Genet. 2012;131(7):1145\u201352.","journal-title":"Hum Genet"},{"issue":"3","key":"1264_CR35","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hep.23768","volume":"52","author":"EK Speliotes","year":"2010","unstructured":"Speliotes EK, Butler JL, Palmer CD, et al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology. 2010;52(3):904\u201312.","journal-title":"Hepatology"},{"issue":"3","key":"1264_CR36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ajg.2013.476","volume":"109","author":"AG Singal","year":"2014","unstructured":"Singal AG, Manjunath H, Yopp AC, et al. The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis. Am J Gastroenterol. 2014;109(3):325\u201334.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1264_CR37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2012.09.036","volume":"58","author":"E Guyot","year":"2013","unstructured":"Guyot E, Sutton A, Rufat P, et al. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis. J Hepatol. 2013;58(2):312\u20138.","journal-title":"J Hepatol"},{"key":"1264_CR38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1471-2350-11-172","volume":"11","author":"K Hotta","year":"2010","unstructured":"Hotta K, Yoneda M, Hyogo H, et al. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. BMC Med Genet. 2010;11:172.","journal-title":"BMC Med Genet"},{"issue":"11","key":"1264_CR39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee QM, Day CP. The genetics of NAFLD. Nat Rev Gastroenterol Hepatol. 2013;10(11):645\u201355.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1264_CR40","doi-asserted-by":"publisher","unstructured":"Guo Y, Xiong Y, Sheng Q, et al. A micro-RNA expression signature for human NAFLD progression. J Gastroenterol. 2016. doi: 10.1007\/s00535-016-1178-0 .","DOI":"10.1007\/s00535-016-1178-0"},{"issue":"11","key":"1264_CR41","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s11695-008-9423-0","volume":"17","author":"HL Huang","year":"2007","unstructured":"Huang HL, Lin WY, Lee LT, et al. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects. Obes Surg. 2007;17(11):1457\u201363.","journal-title":"Obes Surg"},{"issue":"6","key":"1264_CR42","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1440-1746.2004.03362.x","volume":"19","author":"SH Park","year":"2004","unstructured":"Park SH, Kim BI, Yun JW, et al. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol. 2004;19(6):694\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"1264_CR43","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/ajg.2013.349","volume":"108","author":"Y Chang","year":"2013","unstructured":"Chang Y, Jung HS, Yun KE, et al. Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population. Am J Gastroenterol. 2013;108(12):1861\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1264_CR44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00535-014-0948-9","volume":"50","author":"K Nishioji","year":"2015","unstructured":"Nishioji K, Sumida Y, Kamaguchi M, et al. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011\u20132012. J Gastroenterol. 2015;50(1):95\u2013108.","journal-title":"J Gastroenterol"},{"issue":"11","key":"1264_CR45","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00535-013-0911-1","volume":"49","author":"T Nakahara","year":"2014","unstructured":"Nakahara T, Hyogo H, Yoneda M, et al. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. J Gastroenterol. 2014;49(11):1477\u201384.","journal-title":"J Gastroenterol"},{"issue":"9403","key":"1264_CR46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157\u201363.","journal-title":"Lancet"},{"issue":"5","key":"1264_CR47","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.23567","volume":"51","author":"K Das","year":"2010","unstructured":"Das K, Das K, Mukherjee PS, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology. 2010;51(5):1593\u2013602.","journal-title":"Hepatology"},{"issue":"10","key":"1264_CR48","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/j.1440-1746.2012.07222.x","volume":"27","author":"CJ Liu","year":"2012","unstructured":"Liu CJ. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. J Gastroenterol Hepatol. 2012;27(10):1555\u201360.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"1264_CR49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00535-014-0959-6","volume":"50","author":"T Miyake","year":"2015","unstructured":"Miyake T, Kumagi T, Hirooka M, et al. Significance of exercise in nonalcoholic fatty liver disease in men: a community-based large cross-sectional study. J Gastroenterol. 2015;50(2):230\u20137.","journal-title":"J Gastroenterol"},{"issue":"11","key":"1264_CR50","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s00535-015-1058-z","volume":"50","author":"H Takahashi","year":"2015","unstructured":"Takahashi H, Ono M, Hyogo H, et al. Biphasic effect of alcohol intake on the development of fatty liver disease. J Gastroenterol. 2015;50(11):1114\u201323.","journal-title":"J Gastroenterol"},{"issue":"10","key":"1264_CR51","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/jbmr.449","volume":"26","author":"JA Cauley","year":"2011","unstructured":"Cauley JA, Danielson ME, Boudreau R, et al. Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: the Women\u2019s Health Initiative (WHI). J Bone Miner Res. 2011;26(10):2378\u201388.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1264_CR52","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ajg.2009.67","volume":"104","author":"LA Adams","year":"2009","unstructured":"Adams LA, Waters OR, Knuiman MW, et al. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol. 2009;104(4):861\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"1264_CR53","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/j.1440-1746.2006.04698.x","volume":"22","author":"PJ Hsiao","year":"2007","unstructured":"Hsiao PJ, Kuo KK, Shin SJ, et al. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J Gastroenterol Hepatol. 2007;22(12):2118\u201323.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1264_CR54","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jhep.2008.10.010","volume":"50","author":"JG Fan","year":"2009","unstructured":"Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol. 2009;50(1):204\u201310.","journal-title":"J Hepatol"},{"issue":"12","key":"1264_CR55","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1136\/gut.2011.242016","volume":"60","author":"VW Wong","year":"2011","unstructured":"Wong VW, Wong GL, Yip GW, et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut. 2011;60(12):1721\u20137.","journal-title":"Gut"},{"issue":"3","key":"1264_CR56","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/hep.28253","volume":"63","author":"VW Wong","year":"2016","unstructured":"Wong VW, Wong GL, Yeung JC, et al. Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: a prospective cohort study. Hepatology. 2016;63(3):754\u201363.","journal-title":"Hepatology"},{"issue":"2","key":"1264_CR57","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hep.25593","volume":"56","author":"D Kim","year":"2012","unstructured":"Kim D, Choi SY, Park EH, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology. 2012;56(2):605\u201313.","journal-title":"Hepatology"},{"issue":"12","key":"1264_CR58","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/heartjnl-2013-305099","volume":"100","author":"NH Kim","year":"2014","unstructured":"Kim NH, Park J, Kim SH, et al. Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. Heart. 2014;100(12):938\u201343.","journal-title":"Heart"},{"issue":"1","key":"1264_CR59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000341248","volume":"123","author":"BJ Kim","year":"2012","unstructured":"Kim BJ, Kim NH, Kim BS, et al. The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals. Cardiology. 2012;123(1):54\u201361.","journal-title":"Cardiology."},{"issue":"2","key":"1264_CR60","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.atherosclerosis.2008.09.012","volume":"204","author":"HC Kim","year":"2009","unstructured":"Kim HC, Kim DJ, Huh KB. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis. 2009;204(2):521\u20135.","journal-title":"Atherosclerosis."},{"issue":"8","key":"1264_CR61","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00535-014-1024-1","volume":"50","author":"D Liccardo","year":"2015","unstructured":"Liccardo D, Mosca A, Petroni S, et al. The association between retinal microvascular changes, metabolic risk factors, and liver histology in pediatric patients with non-alcoholic fatty liver disease (NAFLD). J Gastroenterol. 2015;50(8):903\u201312.","journal-title":"J Gastroenterol"},{"issue":"6","key":"1264_CR62","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gut.2011.237974","volume":"60","author":"VW Wong","year":"2011","unstructured":"Wong VW, Wong GL, Tsang SW, et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut. 2011;60(6):829\u201336.","journal-title":"Gut"},{"issue":"5","key":"1264_CR63","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1007\/s11033-014-3157-y","volume":"41","author":"XF Lin","year":"2014","unstructured":"Lin XF, Shi KQ, You J, et al. Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study. Mol Biol Rep. 2014;41(5):2989\u201397.","journal-title":"Mol Biol Rep"},{"issue":"7","key":"1264_CR64","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/codi.12172","volume":"15","author":"KW Huang","year":"2013","unstructured":"Huang KW, Leu HB, Wang YJ, et al. Patients with nonalcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy. Colorectal Dis. 2013;15(7):830\u20135.","journal-title":"Colorectal Dis"},{"issue":"1","key":"1264_CR65","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1440-1746.2011.06816.x","volume":"27","author":"YI Lee","year":"2012","unstructured":"Lee YI, Lim YS, Park HS. Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study. J Gastroenterol Hepatol. 2012;27(1):91\u20135.","journal-title":"J Gastroenterol Hepatol"},{"key":"1264_CR66","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-230X-9-56","volume":"9","author":"T Akiyama","year":"2009","unstructured":"Akiyama T, Yoneda M, Inamori M, et al. Visceral obesity and the risk of Barrett\u2019s esophagus in Japanese patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2009;9:56.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"1264_CR67","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.metabol.2007.11.022","volume":"57","author":"Y Chang","year":"2008","unstructured":"Chang Y, Ryu S, Sung E, et al. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism. 2008;57(4):569\u201376.","journal-title":"Metabolism"},{"issue":"10","key":"1264_CR68","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2169\/internalmedicine.50.5043","volume":"50","author":"Y Arase","year":"2011","unstructured":"Arase Y, Suzuki F, Kobayashi M, et al. The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease. Intern Med. 2011;50(10):1081\u20137.","journal-title":"Intern Med"},{"issue":"6","key":"1264_CR69","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","volume":"91","author":"ZM Younossi","year":"2012","unstructured":"Younossi ZM, Stepanova M, Negro F, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore). 2012;91(6):319\u201327.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1264_CR70","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ajg.2011.400","volume":"107","author":"DH Sinn","year":"2012","unstructured":"Sinn DH, Gwak GY, Park HN, et al. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. Am J Gastroenterol. 2012;107(4):561\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"1264_CR71","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/ajg.2015.235","volume":"110","author":"JL Wei","year":"2015","unstructured":"Wei JL, Leung JC, Loong TC, et al. Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy. Am J Gastroenterol. 2015;110(9):1306\u201314.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"1264_CR72","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/ajg.2013.104","volume":"108","author":"C Xu","year":"2013","unstructured":"Xu C, Yu C, Ma H, et al. Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study. Am J Gastroenterol. 2013;108(8):1299\u2013304.","journal-title":"Am J Gastroenterol"},{"key":"1264_CR73","doi-asserted-by":"publisher","unstructured":"Feldman A, Eder SK, Felder TK, et al. Clinical and metabolic characterization of lean Caucasian subjects with non-alcoholic fatty liver. Am J Gastroenterol. 2016. doi: 10.1038\/ajg.2016.318 .","DOI":"10.1038\/ajg.2016.318"},{"issue":"2","key":"1264_CR74","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.22350","volume":"48","author":"D Poorten van der","year":"2008","unstructured":"van der Poorten D, Milner KL, Hui J, et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008;48(2):449\u201357.","journal-title":"Hepatology"},{"issue":"47","key":"1264_CR75","doi-asserted-by":"crossref","first-page":"17932","DOI":"10.3748\/wjg.v20.i47.17932","volume":"20","author":"RN Feng","year":"2014","unstructured":"Feng RN, Du SS, Wang C, et al. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World J Gastroenterol. 2014;20(47):17932\u201340.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1264_CR76","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.atherosclerosis.2008.07.024","volume":"203","author":"KC Sung","year":"2009","unstructured":"Sung KC, Ryan MC, Wilson AM. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Atherosclerosis. 2009;203(2):581\u20136.","journal-title":"Atherosclerosis"},{"key":"1264_CR77","doi-asserted-by":"crossref","first-page":"S909","DOI":"10.1016\/S0016-5085(14)63307-2","volume":"146","author":"AC Dela Cruz","year":"2014","unstructured":"Dela Cruz AC, Bugianesi E, George J, et al. Characteristics and long-term prognosis of lean patients with non-alcoholic fatty liver disease. Gastroenterology. 2014;146:S909.","journal-title":"Gastroenterology"},{"issue":"2","key":"1264_CR78","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.52.2.288","volume":"52","author":"L Castera","year":"2003","unstructured":"Castera L, Hezode C, Roudot-Thoraval F, et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut. 2003;52(2):288\u201392.","journal-title":"Gut"},{"issue":"1","key":"1264_CR79","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/jhep.2003.50267","volume":"38","author":"T Poynard","year":"2003","unstructured":"Poynard T, Ratziu V, McHutchison J, et al. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology. 2003;38(1):75\u201385.","journal-title":"Hepatology"},{"issue":"8","key":"1264_CR80","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cgh.2011.04.029","volume":"9","author":"SR Shah","year":"2011","unstructured":"Shah SR, Patel K, Marcellin P, et al. Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3. Clin Gastroenterol Hepatol. 2011;9(8):688\u201393.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"1264_CR81","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1002\/cncr.22701","volume":"109","author":"JR Pekow","year":"2007","unstructured":"Pekow JR, Bhan AK, Zheng H, et al. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer. 2007;109(12):2490\u20136.","journal-title":"Cancer"},{"issue":"2","key":"1264_CR82","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1440-1746.2001.02407.x","volume":"16","author":"SJ Hwang","year":"2001","unstructured":"Hwang SJ, Luo JC, Chu CW, et al. Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation. J Gastroenterol Hepatol. 2001;16(2):190\u20135.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1264_CR83","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.hepres.2006.02.001","volume":"35","author":"R Yaginuma","year":"2006","unstructured":"Yaginuma R, Ikejima K, Okumura K, et al. Hepatic steatosis is a predictor of poor response to interferon \u03b1-2b and ribavirin combination therapy in Japanese patients with chronic hepatitis C. Hepatol Res. 2006;35(1):19\u201325.","journal-title":"Hepatol Res"},{"issue":"9","key":"1264_CR84","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1872-034X.2010.00692.x","volume":"40","author":"M Kurosaki","year":"2010","unstructured":"Kurosaki M, Hosokawa T, Matsunaga K, et al. Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy. Hepatol Res. 2010;40(9):870\u20137.","journal-title":"Hepatol Res"},{"issue":"20","key":"1264_CR85","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","volume":"370","author":"N Afdhal","year":"2014","unstructured":"Afdhal N, Zeuzem S, Kwo P, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. New Engl J Med. 2014;370(20):1889\u201398.","journal-title":"New Engl J Med"},{"issue":"21","key":"1264_CR86","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1056\/NEJMoa1402338","volume":"370","author":"P Ferenci","year":"2014","unstructured":"Ferenci P, Bernstein D, Lalezari J, et al. ABT-450\/r-ombitasvir and dasabuvir with or without ribavirin for HCV. New Engl J Med. 2014;370(21):1983\u201392.","journal-title":"New Engl J Med"},{"issue":"3","key":"1264_CR87","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hep.27424","volume":"61","author":"EG Meissner","year":"2015","unstructured":"Meissner EG, Lee YJ, Osinusi A, et al. Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients. Hepatology. 2015;61(3):790\u2013801.","journal-title":"Hepatology"},{"issue":"1","key":"1264_CR88","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jhep.2015.08.027","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Stepanova M, Estep M, et al. Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin. J Hepatol. 2016;64(1):29\u201336.","journal-title":"J Hepatol"},{"issue":"1","key":"1264_CR89","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/apt.13429","volume":"43","author":"CL Lai","year":"2016","unstructured":"Lai CL, Wong VW, Yuen MF, et al. Sofosbuvir plus ribavirin for the treatment of patients with chronic genotype 1 or 6 hepatitis C virus infection in Hong Kong. Aliment Pharmacol Ther. 2016;43(1):96\u2013101.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1264_CR90","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jhep.2011.09.013","volume":"56","author":"VW Wong","year":"2012","unstructured":"Wong VW, Wong GL, Chu WC, et al. Hepatitis B virus infection and fatty liver in the general population. J Hepatol. 2012;56(3):533\u201340.","journal-title":"J Hepatol"},{"issue":"1\u20132","key":"1264_CR91","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.cca.2007.01.012","volume":"380","author":"B Luo","year":"2007","unstructured":"Luo B, Wang Y, Wang K. Association of metabolic syndrome and hepatitis B infection in a Chinese population. Clin Chim Acta. 2007;380(1\u20132):238\u201340.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"1264_CR92","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/sj.ijo.0803204","volume":"30","author":"CF Jan","year":"2006","unstructured":"Jan CF, Chen CJ, Chiu YH, et al. A population-based study investigating the association between metabolic syndrome and hepatitis B\/C infection (Keelung community-based integrated screening study no. 10). Int J Obes (Lond). 2006;30(5):794\u20139.","journal-title":"Int J Obes (Lond)"},{"issue":"9","key":"1264_CR93","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1440-1746.2011.06801.x","volume":"26","author":"MV Machado","year":"2011","unstructured":"Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol. 2011;26(9):1361\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1264_CR94","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/gut.2008.157735","volume":"58","author":"GL Wong","year":"2009","unstructured":"Wong GL, Wong VW, Choi PC, et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut. 2009;58(1):111\u20137.","journal-title":"Gut"},{"issue":"5","key":"1264_CR95","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1053\/j.gastro.2007.03.039","volume":"132","author":"KH Kim","year":"2007","unstructured":"Kim KH, Shin HJ, Kim K, et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPAR\u03b3. Gastroenterology. 2007;132(5):1955\u201367.","journal-title":"Gastroenterology"},{"issue":"9","key":"1264_CR96","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1440-1746.2008.05531.x","volume":"23","author":"JP Shi","year":"2008","unstructured":"Shi JP, Fan JG, Wu R, et al. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J Gastroenterol Hepatol. 2008;23(9):1419\u201325.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9865","key":"1264_CR97","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","volume":"381","author":"P Marcellin","year":"2013","unstructured":"Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381(9865):468\u201375.","journal-title":"Lancet"},{"issue":"4","key":"1264_CR98","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","volume":"141","author":"MR Charlton","year":"2011","unstructured":"Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141(4):1249\u201353.","journal-title":"Gastroenterology"},{"issue":"4","key":"1264_CR99","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","volume":"44","author":"M Ekstedt","year":"2006","unstructured":"Ekstedt M, Franzen LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44(4):865\u201373.","journal-title":"Hepatology"},{"issue":"5","key":"1264_CR100","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","volume":"51","author":"BQ Starley","year":"2010","unstructured":"Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51(5):1820\u201332.","journal-title":"Hepatology"},{"issue":"8","key":"1264_CR101","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/ajg.2013.160","volume":"108","author":"TM Welzel","year":"2013","unstructured":"Welzel TM, Graubard BI, Quraishi S, et al. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol. 2013;108(8):1314\u201321.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1264_CR102","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389\u201397.","journal-title":"Gastroenterology."},{"issue":"1","key":"1264_CR103","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00535-009-0128-5","volume":"45","author":"K Michitaka","year":"2010","unstructured":"Michitaka K, Nishiguchi S, Aoyagi Y, et al. Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2010;45(1):86\u201394.","journal-title":"J Gastroenterol"},{"issue":"6","key":"1264_CR104","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12664-010-0069-1","volume":"29","author":"A Duseja","year":"2010","unstructured":"Duseja A. Nonalcoholic fatty liver disease in India\u2014a lot done, yet more required! Indian J Gastroenterol. 2010;29(6):217\u201325.","journal-title":"Indian J Gastroenterol"},{"issue":"3","key":"1264_CR105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/1751-2980.12223","volume":"16","author":"KL Goh","year":"2015","unstructured":"Goh KL, Razlan H, Hartono JL, et al. Liver cancer in Malaysia: epidemiology and clinical presentation in a multiracial Asian population. J Dig Dis. 2015;16(3):152\u20138.","journal-title":"J Dig Dis."},{"issue":"3","key":"1264_CR106","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/hep.24551","volume":"54","author":"DK Wong","year":"2011","unstructured":"Wong DK, Huang FY, Lai CL, et al. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma. Hepatology. 2011;54(3):829\u201336.","journal-title":"Hepatology"},{"issue":"9945","key":"1264_CR107","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766\u201381.","journal-title":"Lancet"},{"issue":"3 Pt 2","key":"1264_CR108","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ajog.2005.06.040","volume":"193","author":"GA Ramos","year":"2005","unstructured":"Ramos GA, Caughey AB. The interrelationship between ethnicity and obesity on obstetric outcomes. Am J Obstet Gynecol. 2005;193(3 Pt 2):1089\u201393.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"1264_CR109","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/gut.2006.109413","volume":"56","author":"DA Corley","year":"2007","unstructured":"Corley DA, Kubo A, Zhao W. Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut. 2007;56(6):756\u201362.","journal-title":"Gut"},{"issue":"21","key":"1264_CR110","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1200\/JCO.2005.11.726","volume":"23","author":"SW Oh","year":"2005","unstructured":"Oh SW, Yoon YS, Shin SA. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol. 2005;23(21):4742\u201354.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1264_CR111","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/gut.2009.205088","volume":"59","author":"VW Wong","year":"2010","unstructured":"Wong VW, Wong GL, Choi PC, et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3\u00a0years. Gut. 2010;59(7):969\u201374.","journal-title":"Gut"},{"issue":"2","key":"1264_CR112","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-1746.2008.05640.x","volume":"24","author":"S Yatsuji","year":"2009","unstructured":"Yatsuji S, Hashimoto E, Tobari M, et al. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol. 2009;24(2):248\u201354.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"1264_CR113","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/ijo.2008.102","volume":"32","author":"T Kelly","year":"2008","unstructured":"Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008;32(9):1431\u20137.","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"1264_CR114","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00535-015-1129-1","volume":"51","author":"K Tokushige","year":"2016","unstructured":"Tokushige K, Hyogo H, Nakajima T, et al. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey. J Gastroenterol. 2016;51(6):586\u201396.","journal-title":"J Gastroenterol"},{"issue":"6","key":"1264_CR115","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264\u201373.","journal-title":"Gastroenterology"},{"issue":"11","key":"1264_CR116","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","volume":"36","author":"M Sasso","year":"2010","unstructured":"Sasso M, Beaugrand M, de Ledinghen V, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36(11):1825\u201335.","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"1264_CR117","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2013.09.002","volume":"60","author":"R Banerjee","year":"2014","unstructured":"Banerjee R, Pavlides M, Tunnicliffe EM, et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol. 2014;60(1):69\u201377.","journal-title":"J Hepatol"},{"issue":"2","key":"1264_CR118","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00535-013-0776-3","volume":"49","author":"K Imajo","year":"2014","unstructured":"Imajo K, Yoneda M, Fujita K, et al. Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis. J Gastroenterol. 2014;49(2):295\u2013304.","journal-title":"J Gastroenterol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1264-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-016-1264-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1264-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T11:35:52Z","timestamp":1718796952000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-016-1264-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,16]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1264"],"URL":"https:\/\/doi.org\/10.1007\/s00535-016-1264-3","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,16]]}}}